144 related articles for article (PubMed ID: 16562674)
21. [A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):147-51. PubMed ID: 23016266
[TBL] [Abstract][Full Text] [Related]
22. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
23. On the origin and growth of gliomas.
Schiffer D; Annovazzi L; Caldera V; Mellai M
Anticancer Res; 2010 Jun; 30(6):1977-98. PubMed ID: 20651342
[TBL] [Abstract][Full Text] [Related]
24. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
[TBL] [Abstract][Full Text] [Related]
25. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
26. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
[TBL] [Abstract][Full Text] [Related]
27. [Isolation and culture of tumor stem cells from human brain glioma tissues].
Huang Q; Dong J; Zhu YD; Zhang QB; Ji XY; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):331-3. PubMed ID: 17044993
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
[TBL] [Abstract][Full Text] [Related]
30. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
31. Detection of cancer stem cell markers in sarcomas.
Veselska R; Skoda J; Neradil J
Klin Onkol; 2012; 25 Suppl 2():2S16-20. PubMed ID: 23581011
[TBL] [Abstract][Full Text] [Related]
32. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC
Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333
[TBL] [Abstract][Full Text] [Related]
33. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
[TBL] [Abstract][Full Text] [Related]
34. Intermediate filament nestin expressions in human cord blood monocytes (HCMNCs).
Ha Y; Lee JE; Kim KN; Cho YE; Yoon DH
Acta Neurochir (Wien); 2003 Jun; 145(6):483-7. PubMed ID: 12836073
[TBL] [Abstract][Full Text] [Related]
35. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
Shu Q; Wong KK; Su JM; Adesina AM; Yu LT; Tsang YT; Antalffy BC; Baxter P; Perlaky L; Yang J; Dauser RC; Chintagumpala M; Blaney SM; Lau CC; Li XN
Stem Cells; 2008 Jun; 26(6):1414-24. PubMed ID: 18403755
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
Pallini R; Ricci-Vitiani L; Banna GL; Signore M; Lombardi D; Todaro M; Stassi G; Martini M; Maira G; Larocca LM; De Maria R
Clin Cancer Res; 2008 Dec; 14(24):8205-12. PubMed ID: 19088037
[TBL] [Abstract][Full Text] [Related]
38. An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors.
Xiao ZY; Tang H; Xu ZM; Yan ZJ; Li P; Cai YQ; Jiang XD; Xu RX
Cancer Biol Ther; 2011 Jun; 11(11):974-80. PubMed ID: 21502808
[TBL] [Abstract][Full Text] [Related]
39. Radiation resistance and stem-like cells in brain tumors.
Hambardzumyan D; Squatrito M; Holland EC
Cancer Cell; 2006 Dec; 10(6):454-6. PubMed ID: 17157785
[TBL] [Abstract][Full Text] [Related]
40. Stem cell marker CD133 affects clinical outcome in glioma patients.
Zeppernick F; Ahmadi R; Campos B; Dictus C; Helmke BM; Becker N; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende CC
Clin Cancer Res; 2008 Jan; 14(1):123-9. PubMed ID: 18172261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
